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Abstract
Background: To learn about the molecular etiology of strabismus, we are studying the genetic
basis of 'congenital fibrosis of the extraocular muscles' (CFEOM). These syndromes are
characterized by congenital restrictive ophthalmoplegia affecting muscles in the oculomotor and
trochlear nerve distribution. Individuals with the classic form of CFEOM are born with bilateral
ptosis and infraducted globes. When all affected members of a family have classic CFEOM, we
classify the family as a CFEOM1 pedigree. We have previously determined that a CFEOM1 gene
maps to the FEOM1 locus on chromosome 12cen. We now identify additional pedigrees with
CFEOM1 to determine if the disorder is genetically heterogeneous and, if so, if any affected
members of CFEOM1 pedigrees or sporadic cases of classic CFEOM harbor mutations in ARIX, the
CFEOM2 disease gene.
Results: Eleven new CFEOM1 pedigrees were identified. All demonstrated autosomal dominant
inheritance, and nine were consistent with linkage to FEOM1. Two small CFEOM1 families were
not linked to FEOM1, and both were consistent with linkage to FEOM3. We screened two CFEOM1
families consistent with linkage to FEOM2 and 5 sporadic individuals with classic CFEOM and did
not detect ARIX mutations.
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BMC Genetics 2002, 3 http://www.biomedcentral.com/1471-2156/3/3Conclusions: The phenotype of two small CFEOM1 families does not map to FEOM1, establishing
genetic heterogeneity for this disorder. These two families may harbor mutations in the FEOM3
gene, as their phenotype is consistent with linkage to this locus. Thus far, we have not identified
ARIX mutations in any affected members of CFEOM1 pedigrees or in any sporadic cases of classic
CFEOM.
Background
Congenital fibrosis of the extraocular muscles (CFEOM)
and Duane syndrome (DS) are complex strabismus disor-
ders that present with congenital restrictive ophthalmo-
plegia with or without ptosis. These disorders were
traditionally believed to reflect primary structural extraoc-
ular muscle (EOM) anomalies and have been referred to
as 'congenital fibrosis syndromes' [1]. Neuropathology
studies of DS [2,3] and one form of CFEOM (CFEOM1)
[4], and the identification of ARIX as the gene mutated in
a second form of CFEOM (CFEOM2) [5], however, sup-
port our hypothesis that CFEOM results from maldevel-
opment of the oculomotor (nIII) and/or trochlear (nIV)
nuclei and DS results from maldevelopment of the abdu-
cens (nVI) nucleus. The continued definition of these phe-
notypes and identification of the underlying disease genes
will assist clinical diagnostics and lead to a better under-
standing of the unique developmental features of the oc-
ulomotor lower motor neuron unit.
Although several distinct CFEOM phenotypes have been
defined [6–8], each likely resulting from maldevelopment
of a unique combination of alpha motor neurons in nIII
and/or nIV, most reports of CFEOM families describe a
stereotypical clinical phenotype. The affected members of
these pedigrees are born with bilateral ptosis and restric-
tive ophthalmoplegia. The primary vertical position of
each eye is downward and cannot be elevated above the
midline. On forced duction testing there is resistance to
passive movement of the globe. Although the primary po-
sition of both eyes is infraducted, there is variability in the
secondary position of each eye (i.e. exotropic, esotropic,
or neutral), and the degree of residual horizontal move-
ment within the lower quadrants (full to completely re-
stricted). This CFEOM phenotype was first described in
the medical literature in 1840 [9] and was recognized to
occur as a familial trait in 1879 [10]. Subsequently, fami-
lies segregating this phenotype have been published un-
der myriad names [1,4,6,11–21]. We now refer to
individuals with this phenotype as having "classic CFE-
OM" and to families in which all affected members have
this phenotype as " CFEOM1 pedigrees". We previously
mapped a CFEOM1 locus, referred to as FEOM1, to a ≤ 3
cM region spanning the centromere of chromosome 12,
flanked by D12S1584 (AFM136xf6) on the p-arm and
D12S1668 (AFMb320wd9) on the q-arm [6,15].
In addition to families with CFEOM1, we have identified
several less common familial CFEOM phenotypes
(CFEOM2 and CFEOM3). These phenotypes are classified
as CFEOM based on the presence of affected members
with congenital restrictive ophthalmoplegia affecting ex-
traocular muscles in the nIII/nIV distribution. By defini-
tion, however, one or more affected family members do
not have the classic CFEOM phenotype. In families with
CFEOM2, the eyes of affected family members are fixed in
an exotropic, or outward, position. Thus far, this pheno-
type segregates as an autosomal recessive trait and maps to
the FEOM2 locus on chromosome 11q13 [8], and affected
individuals carry homozygous mutations in ARIX[5].
ARIX encodes a homeodomain transcription factor re-
quired for nIII and nIV development in mice and ze-
brafish [22,23]. In families with CFEOM3, the CFEOM
phenotype is variably expressed. Some affected members
have classic CFEOM. Others, however, are unilaterally af-
fected, the primary position of the eye is orthotropic rath-
er than infraducted, and/or the eye can be raised into the
upper quadrants. Thus far, this phenotype segregates as an
autosomal dominant trait and maps to either FEOM3 on
16qter [7] or to FEOM1[24].
In our attempt to understand phenotype-genotype corre-
lations between specific CFEOM phenotypes and FEOM
loci, we noted that the CFEOM1 phenotype in all pedi-
grees reported to date maps to the FEOM1 locus. To deter-
mine if CFEOM1 is indeed genetically homogeneous, we
identified all unpublished CFEOM1 pedigrees in our da-
tabase, analyzed them for linkage to the FEOM loci, and
found that most but not all were consistent with linkage
to FEOM1. The two small pedigrees not linked to FEOM1
were consistent with linkage to FEOM3. In addition, to
further define the spectrum of human ARIX mutations, we
identified all CFEOM1 families consistent with linkage to
FEOM2 or sporadic individuals with classic CFEOM and
determined that none harbored mutations in the ARIX
gene.
Results
From our database, 33 pedigrees were of sufficient size
and had sufficient clinical data and 14 sporadic individu-
als had sufficient clinical data to qualify for the study. Of
these, 20 pedigrees met CFEOM1 and 5 sporadic individ-
uals met classic CFEOM inclusion criteria. Although not
an inclusion criterion for the study, the CFEOM1 pheno-Page 2 of 8
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inant trait with full penetrance. The phenotype in 9 of the
20 pedigrees was previously demonstrated to map to the
FEOM1 locus [6,15,25,26] (Table 1). Therefore, the re-
maining 11 families were included in this study (Figs. 1 &
2, Table 1, and see additional files 1–3 [Additional File 1,
Additional File 2, Additional File 3].
The 11 families are ethnically diverse, not consanguine-
ous and, to the best of our knowledge, unrelated. Eight of
the families reside in the US and are of mixed European
ancestry (BJ, AG, AJ, AH, CT, E, K, BT), while families CZ,
T, and BC are of Italian, Irish, and Japanese ancestry, re-
spectively. Family history of CFEOM in several previous
generations was documented in two pedigrees (AG, T),
and a previous family history was recounted but could not
be corroborated in five others (BJ, AJ, AH, E, K). In con-
trast, in pedigrees CZ, BC, CT and BT, neither the parents
nor more distant relatives of the eldest affected family
member were reportedly affected. Examination of individ-
uals I–1 and I–2 of pedigrees BC and CT confirmed their
unaffected status. Individuals I–1 and I–2 in pedigrees CZ
and BT were deceased. These data suggest that the
CFEOM1 mutation rate is not negligible. Cytogenetic
analyses, when performed, did not reveal abnormalities
(Table 1).
Nine of the 11 CFEOM1 pedigrees contain too few partic-
ipants to establish linkage to a specific locus. Haplotype
analysis of these families using multiple markers that span
the critical region of a given locus can, however, eliminate
linkage to the locus, determine genetic heterogeneity, and
Figure 1
Haplotype analysis of pedigrees BJ, CZ, AG, AJ, AH, T, CT, BC, and E at the FEOM1 locus. Black symbols denote those individ-
uals who are clinically affected with classic CFEOM. Genotyping data and schematic segregating haplotype bars for chromo-
some 12cen markers are shown below the symbol for each study participant. Allele sizes here and in figure 2 were assigned as
linkage studies were performed are not equivalent when compared between families. Black bars denote the potential disease-
associated region. Diagonally hatched or white bars highlight the inheritance of the non-disease-associated haplotypes. Refer-
ences to specific individuals within the text refer to the generation number (Roman numeral) and position within generation
(Arabic numeral). In all 9 pedigrees each family's disease-associated haplotype is inherited by all CFEOM1 individuals and by no
asymptomatic individuals.Page 3 of 8
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from a mutation at a given locus, haplotype analysis at
that locus will be consistent with linkage. If the phenotype
does not result from a mutation at a given locus, however,
haplotype data from a small family may be consistent or
inconsistent with linkage. Thus, haplotype data in a small
family that is consistent with linkage can result either
from a disease mutation at that locus or by chance. Hap-
lotype data in a small family that is inconsistent with link-
age strongly suggests that the family's phenotype is not
linked to the locus.
Linkage to FEOM1
Genetic analyses of the two largest families (BJ, CZ) estab-
lished linkage of their phenotype to the FEOM1 locus
(Fig. 1, Table 1 & see Additional File 1). Maximum lod
scores of 3.01 were obtained at a theta value of zero for the
fully informative markers D12S59 and D12S1048 in fam-
ily BJ, and the fully informative markers D12S1648,
D12S345, and D12S59 in family CZ.
Linkage to FEOM1 was ruled out in family BT (see Addi-
tional file 1). A lod score of -2 was obtained at a theta val-
ue of 0.04 for the fully informative markers D12S1621,
D12S59 and D12S1668. The FEOM1 critical region is ≤ 3
cM, and a theta of 0.04 corresponds to a genetic distance
of approximately 4 cM, thus eliminating linkage of this
family's CFEOM disease gene to the entire FEOM1 critical
region. Exclusion of linkage to the FEOM1 locus is further
supported by haplotype analysis of this family (Fig. 2c).
The affected sister and brother inherit different FEOM1
haplotypes from their affected mother, and the brother's
affected daughter inherits her unaffected paternal grandfa-
ther's FEOM1 haplotype, thus proving non-association
between the FEOM1 haplotype and the disease pheno-
type.
The eight remaining CFEOM pedigrees were too small to
produce statistically significant lod scores; however, seven
of the eight families displayed haplotype and linkage data
consistent with linkage to the FEOM1 locus (Fig. 1, see
Additional File 1). Genetic and haplotype analysis of all
nine families consistent with linkage to the FEOM1 locus
did not reveal any recombination events within the previ-
ously defined FEOM1 critical region.
The smallest family, K, revealed haplotype and linkage
data that was inconsistent with linkage to the FEOM1 lo-
cus (Fig. 2a, see Additional File 1). A lod score of -2 was
obtained at a theta value of 0.002 for the only two inform-
ative markers, D12S59 and D12S1090. These theta values
eliminate linkage to only 0.8 cM of the < 3 cM FEOM1 crit-
ical region and, therefore, this locus cannot be formally
ruled out. Nevertheless, the minimum number of recom-
bination events in this family occurs only if the affected
son and daughter inherit different FEOM1 haplotypes
from their affected mother, thus strongly suggesting that
the disease gene in this family does not map to the chro-
mosome 12 locus.
Genetic heterogeneity was tested taking into account the
eleven new families. Admixture analysis of the two-point
data with the HOMOG program showed evidence for
linkage to FEOM1 with heterogeneity for both markers
tested (D12S345 and D12S1048). Chi-squares of 34.601
and 40.377 were obtained for D12S345 and D12S1048 re-
spectively which resulted in significant likelihood ratios
of 3.26 × 107 and 5.86 × 108. Alpha (the proportion of
linked families) was 0.90.
Figure 2
Haplotype analysis for pedigrees K at the (a)FEOM1 and
(b)FEOM3 loci and BT at the (c)FEOM1 and (d)FEOM3 loci.
Symbols are defined in the legend to figure 1. In each family
the CFEOM1 phenotype is co-inherited with FEOM3 markers
and not with FEOM1 markers.Page 4 of 8
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All families except BJ and CZ were analyzed for linkage to
the 5.6 cM FEOM3 locus flanked by D16S486 and 16qter.
Of the seven small families consistent with linkage to
FEOM1, only the largest (AG) can be definitively excluded
from linkage to FEOM3 (see Additional File 2). Five of the
remaining families (AJ, AH, T, BC, CT) showed haplotype
data inconsistent with linkage to FEOM3, but the theta
values obtained at lod scores of -2 were insufficient to rule
out the entire FEOM3 critical region.
The two families whose phenotype did not map to
FEOM1 (K, BT) had haplotype and linkage data consistent
with linkage to FEOM3 (Fig. 2b & 2d, see Additional File
2). In addition, one of the small families consistent with
linkage to the FEOM1 locus (E) had haplotype and link-
age data that was also consistent with linkage to the
FEOM3 locus (see Additional File 2).
Linkage to FEOM2
All families whose phenotype was not linked to FEOM1 or
FEOM3 were tested for linkage to FEOM2. Assuming au-
tosomal dominant inheritance with complete penetrance,
two families (AG, E) are not linked and five families are
inconsistent with linkage (AJ, AH, T, CT, BT) to the
FEOM2 locus (see Additional File 3). Family BC is consist-
ent with linkage to both the FEOM2 and FEOM1 loci
(maximum lod score 0.3 at both loci), and family K is
consistent with linkage to both the FEOM2 and FEOM3
loci (maximum lod score 0.3 at both loci).
ARIX mutation analysis
Genomic DNA samples from affected member of pedigree
BC and K and 5 sporadic individuals with classic CFEOM
were used as templates to sequence the three ARIX exons
and flanking introns. No mutations were identified.
Discussion
We have established clinical criteria for classic CFEOM
and CFEOM1, and have identified 5 sporadic individuals
with classic CFEOM and 20 pedigrees with CFEOM1. Of
these 20 pedigrees, 18 are linked, or consistent with link-
age, to the FEOM1 locus. Two small CFEOM1 pedigrees
are not consistent with linkage, however, establishing that
CFEOM1 is genetically heterogeneous.
Eleven of the 20 pedigrees are large enough to establish
linkage to a specific locus; we previously reported that the
CFEOM1 phenotype in 9 of these pedigrees maps to the
FEOM1 locus [6,15,25,26] and we now demonstrate that
the remaining two also map to FEOM1. Our analysis of
the remaining 9 CFEOM1 pedigrees demonstrates that 6
most likely result from mutations in the FEOM1 gene. Five
of these 6 are consistent with linkage to FEOM1 and are ei-
ther not linked or not consistent with linkage to FEOM2
and FEOM3. One is consistent with linkage to FEOM1
and not FEOM3 and, although consistent with linkage to
FEOM2, ARIX mutations were not identified. Therefore,
although not proved, the CFEOM1 phenotype in these 6
families seems likely to result from mutations in the
FEOM1 gene. The phenotype of a seventh family, E, is
Table 1: Summary of the genetic analysis of CFEOM1 pedigrees
Pedigree CFEOM 
Phenotype
Inheritance Forced 
Ductions
Cytogenetic 
analysis
FEOM1 FEOM3 FEOM2 ARIX mutations Publication
A CFEOM1 AD + normal LINKED refs. [6,15]
B CFEOM1 AD + normal LINKED refs. [6,15]
C CFEOM1 AD + not done LINKED ref. [15]
H CFEOM1 AD + normal LINKED ref. [15]
AA CFEOM1 AD + normal LINKED ref. [15]
AC CFEOM1 AD + normal LINKED ref. [15]
AD CFEOM1 AD + normal LINKED ref. [15]
CD CFEOM1 AD + not done LINKED ref. [25]
CB CFEOM1 AD not done not done c/w linkage nc/w linkage NOT LINKED ref. [26]
BJ CFEOM1 AD + normal LINKED current
CZ CFEOM1 AD + normal LINKED current
AG CFEOM1 AD + normal c/w linkage NOT LINKED NOT LINKED current
AJ CFEOM1 AD + not done c/w linkage nc/w linkage nc/w linkage current
AH CFEOM1 AD + normal c/w linkage nc/w linkage nc/w linkage current
T CFEOM1 AD + not done c/w linkage nc/w linkage nc/w linkage current
CT CFEOM1 AD + normal c/w linkage nc/w linkage nc/w linkage current
BC CFEOM1 AD + not done c/w linkage nc/w linkage (c/w linkage) none current
E CFEOM1 AD + normal c/w linkage c/w linkage NOT LINKED current
K CFEOM1 AD + normal nc/w linkage c/w linkage (c/w linkage) none current
BT CFEOM1 AD + normal NOT LINKED c/w linkage nc/w linkage current
AD = autosomal dominant; + = positive forced duction testing for restriction; c/w linkage = consistent with linkage; nc/w li nkage = not consistent with linkage.Page 5 of 8
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will be screened for mutations at both these loci.
In contrast to the 18 pedigrees whose CFEOM1 phenotype
is consistent with linkage to FEOM1, pedigree BT is not
linked to FEOM1 and pedigree K is inconsistent with link-
age to this locus. It is notable that haplotype analysis of
both these small CFEOM1 families demonstrates co-in-
heritance with the FEOM3 locus. In the reported family
whose autosomal dominant CFEOM3 phenotype maps to
the FEOM3 locus, 9 of the 17 affected members had clas-
sic CFEOM. Our current data now suggests that, at least in
small pedigrees, CFEOM1 can also map to the FEOM3 lo-
cus. It will require the identification of additional large
CFEOM1 families to determine if they too can map to this
locus.
ARIX, which encodes a transcription factor critical to nIII
and nIV development in mice and zebrafish [22,23], was
recently identified as the FEOM2 gene mutated in affected
members of CFEOM2 families [5]. It was unknown, how-
ever, if classic CFEOM may also result from mutations in
this gene. We now find that we are unable to identify ARIX
mutations underlying classic CFEOM in either sporadic
cases or in individuals from CFEOM1 families.
This finding is consistent with our prediction that, com-
pared to ARIX, the genes mutated in CFEOM1 may have a
more restricted function in the development of nIII and
that their expression may actually be regulated by ARIX.
This prediction is based on the CFEOM1 phenotype and
on the neuropathological study of an affected member of
a CFEOM1 pedigree whose disease gene maps to the
FEOM1 locus. This study revealed absence of the superior
division of the oculomotor nerve and the corresponding
central caudal and medial nIII subnuclei, and marked ab-
normalities of the levator palpebrae superioris and supe-
rior rectus muscles [4]. These findings suggest that while
ARIX is necessary for both nIII and nIV development, the
CFEOM1 genes may be necessary for the development of
only these two specific nIII subnuclei.
Conclusions
The genetic analysis of the 11 CFEOM1 pedigrees in this
report demonstrates that this disorder is genetically heter-
ogeneous. While the phenotype of all large CFEOM1 ped-
igrees analyzed thus far map to the FEOM1 locus, smaller
CFEOM1 pedigrees may harbor mutations in the FEOM3
gene. The CFEOM1 phenotype does not, however, appear
to result from mutations in ARIX. The CFEOM1 families
identified in this study contribute critical alleles toward
the identification of the mutated FEOM1 and FEOM3
genes. Once identified, we anticipate that the study of the
function of these genes will contribute to our understand-
ing of midbrain motor neuron development.
Materials and Methods
Subjects
We established inclusion criteria for this study as follows.
First, we established criteria for a "classic CFEOM individ-
ual" as an individual with congenital nonprogressive bi-
lateral ophthalmoplegia and ptosis, an infraducted
primary position of each eye with the inability to raise ei-
ther eye above the midline, and forced duction testing
positive for restriction, if testing was performed. We then
established criteria for a "CFEOM1 pedigree" as a family
in which every affected member met the criteria for "clas-
sic CFEOM". Second, we reviewed all participants en-
rolled in our ongoing CFEOM study and determined
which individuals and which pedigrees met these two cri-
teria. For a pedigree to be considered, we required clinical
examination records and/or photographs/videos of the
primary positions of gaze for all affected study partici-
pants. Third, from these CFEOM1 pedigrees we identified
those with a family structure sufficient for linkage analy-
sis. Pedigrees were required to have affected study partici-
pants in three or more generations, or affected study
participants in two generations with at least two partici-
pating offspring of affected individuals, or two or more af-
fected study participants within one generation. In this
way we did not assume a mode of inheritance. Lastly, spo-
radic individuals with classic CFEOM were screened for
ARIX mutations. The study was approved by the Chil-
dren's Hospital institutional review board, and all study
participants signed informed consent forms. Our meth-
ods adhered to the Declaration of Helsinki for research in-
volving human subjects.
Molecular studies
Blood samples were obtained from all participating fami-
ly members, and lymphocyte DNA was extracted using the
Puregene kit (Gentra, Research Triangle Park, NC). Chro-
mosome analyses of GTG banded metaphase cells at a 400
band level minimum resolution were performed on one
or more affected family members of each family whenever
possible to rule out cytogenetic abnormalities. All families
were analyzed for linkage to the FEOM1 locus. Families
not linked to the FEOM1 locus were also analyzed for
linkage to the FEOM2 and FEOM3 loci. Linkage studies
were conducted using three or more locus specific poly-
morphic DNA micro satellite markers for each family. The
FEOM1 markers included D12S1648, D12S61,
D12S1584, D12S1621, D12S345, D12S59, D12S2080,
D12S1048, D12S1668, and D12S1090[6,15]. The FEOM2
markers included D11S1337, D11S4162, D11S4196,
D11S1314, and D11S1369[8]. The FEOM3 markers in-
cluded D16S539, D16S3077, D16S498, D16S486,
D16S476, D16S3063, D16S689, D16S2621, D16S303,
and D16S3407[7]. The primer sequences for these poly-
morphisms are available from the Genome Database  [ht-
tp://gdbwww.gdb.org] . Unlabeled primers werePage 6 of 8
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www.genosys.com] . Fluorescently labeled primers were
purchased from Research Genetics, Inc.  [http://www.re-
searchgenetics.com] . Radioactive products were made by
30 cycles of PCR amplification of 10-µl reaction volumes
containing 10–30 ng of genomic DNA, 40 ng of each
primer, 200 µM each of dATP, dTTP, dGTP, and dCTP, 1
µCi α-32P-dCTP (3,000 Ci mmol-1) and 0.5 U Taq
polymerase (Perkin Elmer). The radioactively labeled PCR
products were separated on 6% denaturing polyacryla-
mide sequencing gels, and the alleles were visualized by
autoradiography [6]. For the fluorescently labeled prod-
ucts, α-32P-dCTP was omitted, fluorescent primers were
used, and the products were analyzed in an ABI PrismTM
377 DNA Sequencer (Perkin Elmer) following the manu-
facturer's specifications.
Lod score calculations
An individual was scored as affected based on clinical ex-
amination records and/or photographs of primary posi-
tion of gaze. Lod scores were calculated using the Fastlink
version 3.0 package of programs [27], assuming autosom-
al dominant inheritance with complete penetrance, and a
disease incidence of 1 in 1,000,000 births, as described
previously [7,8]. Because of the absence of specific allele
frequencies for each of the ethnic groups represented in
the study, we assumed ten marker alleles of equal frequen-
cy. To assess nonallelic heterogeneity linkage data from
two FEOM1 markers spanning the FEOM1 critical region
(D12S345 and D12S1048) were analyzed using a HO-
MOG version 3.35 program [28].
ARIX mutation detection
ARIX was PCR amplified from genomic DNA using five
primer sets and sequenced on an automated ABI 377 DNA
seqeuncer (PE-Applied Biosystems) as described previous-
ly [5].
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